Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Agilon Health (AGL) Depreciation & Amortization (IS) (2020 - 2025)

Agilon Health (AGL) has disclosed Depreciation & Amortization (IS) for 6 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (IS) rose 7.31% year-over-year to $7.0 million, compared with a TTM value of $28.6 million through Dec 2025, up 16.89%, and an annual FY2025 reading of $28.6 million, up 16.89% over the prior year.
  • Depreciation & Amortization (IS) was $7.0 million for Q4 2025 at Agilon Health, down from $7.4 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $7.8 million in Q3 2023 and bottomed at -$439000.0 in Q4 2021.
  • Average Depreciation & Amortization (IS) over 5 years is $4.9 million, with a median of $4.7 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (IS) plummeted 111.96% in 2021, then soared 989.98% in 2022.
  • Year by year, Depreciation & Amortization (IS) stood at -$439000.0 in 2021, then skyrocketed by 989.98% to $3.9 million in 2022, then skyrocketed by 31.74% to $5.1 million in 2023, then increased by 26.17% to $6.5 million in 2024, then rose by 7.31% to $7.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (IS) for AGL at $7.0 million in Q4 2025, $7.4 million in Q3 2025, and $7.3 million in Q2 2025.